What Percentage of ROP Cases Resolve Without Treatment?
At a Glance
Across broad groups of premature infants, about 84% to 88% of retinopathy of prematurity cases resolve without laser, injections, or surgery. Your baby's individual outlook depends on disease severity and location, so every eye exam matters.
For many parents, a diagnosis of retinopathy of prematurity (ROP) brings worry, but it is important to know that many early cases improve without intervention. Across broad groups of premature infants, studies have found that roughly 84% to 88% of babies with ROP will see the condition resolve without laser therapy, injections, or surgery [1][2]. Eye doctors call this natural improvement spontaneous regression.
However, no statistic can predict your individual baby’s outcome. The chances of ROP going away depend heavily on the specific characteristics of your baby’s eyes, and even mild cases require scheduled, strict monitoring.
How Doctors Determine Your Baby’s Risk
Your pediatric ophthalmologist does not just look at the “stage” of ROP to determine if it will go away. They evaluate several factors together to decide if the disease is likely to regress or if it requires urgent treatment (often called Type 1 ROP) [3][4].
- Stage: This describes the appearance of the abnormal blood vessel growth.
- Stages 1 and 2 (Mild): In observational studies, most mild cases regress naturally. One specific study found that 100% of Stage 1 cases and about 95% of Stage 2 cases resolved without treatment [1].
- Stage 3 (Moderate to Severe): The likelihood of spontaneous regression drops considerably at this stage (around 22% overall in one study) [1]. While some very specific, stable cases of Stage 3 that do not meet treatment criteria may persist past 40 weeks postmenstrual age (time since the start of pregnancy) and eventually resolve [5], this is never a reason to delay care. Any ROP that meets the criteria for treatment requires prompt action [6].
- Stages 4 and 5: These stages indicate partial (Stage 4) or total (Stage 5) detachment of the retina. Stage 4 is divided into 4A (not involving the central vision area) and 4B (involving the center). These advanced stages require urgent evaluation by a retinal specialist for surgical treatment to protect vision [7][8].
- Zone: This describes where the ROP is located in the eye. Disease closer to the center of the retina (Zone I) is more serious and less likely to resolve on its own than disease at the outer edges (Zones II or III) [9].
- Plus Disease: This is a high-risk sign where the blood vessels become abnormally wide and twisted. Plus disease is a major warning sign that the ROP is severe and may require immediate, urgent treatment [1][6].
Factors That Make Treatment More Likely
- Gestational age and weight: Extremely premature babies (born before 28 weeks) or those with very low birth weights are more likely to require treatment. When their ROP does resolve naturally, the improvement process often takes longer [10].
- Aggressive Posterior ROP: This is a rare, fast-moving form of the disease that typically does not resolve on its own and requires prompt medical care [1].
What “Spontaneous Regression” Really Means
When ROP regresses spontaneously, it means the active, abnormal blood vessel growth has improved. However, regression does not guarantee perfect vision later in life [11]. Children who had ROP and prematurity are still at a higher risk for long-term eye conditions, such as needing glasses (refractive error), “lazy eye” (amblyopia), or misaligned eyes (strabismus). Your baby will still need routine vision follow-ups even after the immediate risk of ROP has passed.
Why Every Scheduled Exam Matters
Even if your baby has mild ROP with a high statistical chance of resolving naturally, attending every follow-up eye exam is critical.
ROP can worsen rapidly, and parents cannot see it by simply looking at their baby’s eyes—there are no outward symptoms or signs of distress [12]. Only a pediatric ophthalmologist can monitor the retina using specialized equipment to see if the disease is regressing or if it has reached a threshold that requires treatment to prevent vision loss [3].
The specialist will decide exactly when ROP screening can safely end based on defined medical criteria (such as the blood vessels being sufficiently grown or the baby reaching a certain age). If you miss an appointment due to transportation or discharge logistics, do not wait for the next routine visit or for symptoms to appear. Contact the eye care team or your NICU social worker promptly to reschedule, as timing is crucial to protecting your baby’s sight.
Common questions in this guide
How many babies with ROP improve without treatment?
Which types of ROP are most likely to go away on their own?
Can Stage 3 ROP resolve without treatment?
Why does my baby need eye exams if ROP may improve on its own?
Does ROP regression mean my baby's vision will be normal?
One line in your results can change your plan.
A plus disease finding on an eye exam may mean ROP needs urgent treatment, so discuss it with your specialist. We check your results against the latest research to help you prepare for what’s next.
Related questions
Show more
Get notified when new evidence is published on Retinopathy of prematurity.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
Clinical feature and predictive factor analysis for spontaneous regression of retinopathy of prematurity in a Chinese population.
Li YA, Zhou XH, Cai XJ, Yang CH
International journal of ophthalmology 2022; (15(12)):1978-1984 doi:10.18240/ijo.2022.12.13.
PMID: 36536972 - 2
Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.
Quinn GE, Ying GS, Bell EF, et al.
JAMA ophthalmology 2018; (136(12)):1383-1389 doi:10.1001/jamaophthalmol.2018.4290.
PMID: 30326046 - 3
Role of cytokines and treatment algorithms in retinopathy of prematurity.
Hartnett ME
Current opinion in ophthalmology 2017; (28(3)):282-288 doi:10.1097/ICU.0000000000000360.
PMID: 28141765 - 4
Screening Examination of Premature Infants for Retinopathy of Prematurity.
Fierson WM, , , et al.
Pediatrics 2018; (142(6)) doi:10.1542/peds.2018-3061.
PMID: 30478242 - 5
Natural history and outcomes of stage 3 retinopathy of prematurity persisting beyond 40 weeks of post-menstrual age: Dilemma for treatment and follow up.
Koucheki R, Isaac M, N Tehrani N, Mireskandari K
Clinical & experimental ophthalmology 2020; (48(7)):956-963 doi:10.1111/ceo.13827.
PMID: 32643860 - 6
Clinical characteristics, risk factors and short-term prognosis of retinopathy of prematurity complicated with retinal hemorrhage.
Li Q, Han T, Wang Z, et al.
European journal of ophthalmology 2022; 11206721221136314 doi:10.1177/11206721221136314.
PMID: 36314415 - 7
Current concepts and techniques of vitrectomy for retinopathy of prematurity.
Kusaka S
Taiwan journal of ophthalmology 2018; (8(4)):216-221 doi:10.4103/tjo.tjo_102_18.
PMID: 30637193 - 8
Stage 5 retinopathy of prematurity: An update.
Sen P, Jain S, Bhende P
Taiwan journal of ophthalmology 2018; (8(4)):205-215 doi:10.4103/tjo.tjo_61_18.
PMID: 30637192 - 9
Risk Score for Predicting Treatment-Requiring Retinopathy of Prematurity (ROP) in the Telemedicine Approaches to Evaluating Acute-Phase ROP Study.
Ying GS, VanderVeen D, Daniel E, et al.
Ophthalmology 2016; (123(10)):2176-82.
PMID: 27491396 - 10
Temporal Profile of Retinopathy of Prematurity in Extremely Premature Compared to Premature Infants.
Venincasa VD, Bugg V, Dvorak J, et al.
Journal of pediatric ophthalmology and strabismus 2019; (56(2)):116-123 doi:10.3928/01913913-20190205-01.
PMID: 30889266 - 11
Zone II stage 2 retinopathy of prematurity without plus disease: long-term follow-up and predictors of persistent avascular retina.
Isik Eker P, Esen E, Yapıcıoglu Yıldiztas H, et al.
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2026; 105306 doi:10.1016/j.jaapos.2026.105306.
PMID: 42822807 - 12
Risk factor analysis for the development and progression of retinopathy of prematurity.
Chang JW
PloS one 2019; (14(7)):e0219934 doi:10.1371/journal.pone.0219934.
PMID: 31318921
This page explains general ROP regression statistics for informational purposes only and does not constitute medical advice. Your baby's pediatric ophthalmologist should interpret the findings and set the follow-up or treatment plan.